Core Insights - Intuitive Surgical's shares have decreased by approximately 26% from their peak earlier this year, yet long-term shareholders have seen a remarkable increase of 5,490% over the past 20 years [1] Competitive Landscape - Intuitive Surgical faces competitive pressure from Medtronic, which has introduced the Hugo RAS system that showed successful results in a urologic procedure study [2] - Medtronic's Hugo RAS system received its first marketing approval from European regulators in 2021, and an application for U.S. marketing is expected to be submitted to the FDA, potentially allowing sales to begin in early 2026 [4] Operational Performance - In 2024, da Vinci systems conducted 2.68 million procedures, and the company expanded its da Vinci machine installations by 1,790 to a total of 11,040 globally [5] - Hospitals investing in da Vinci systems also commit significant resources to training surgical teams, creating high switching costs that hinder competitors like Medtronic from capturing market share [5] Financial Metrics - Despite the recent decline, Intuitive Surgical's shares are trading at over 55 times earnings estimates, indicating a high valuation [6] - The company anticipates a procedure volume increase of 15.5% to 17% for the year, suggesting strong growth potential [6]

Core Viewpoint - A class action lawsuit has been filed against Semler Scientific, Inc. for failing to disclose a material investigation by the U.S. Department of Justice regarding potential violations of the False Claims Act [2][3]. Group 1: Allegations and Investigations - The lawsuit alleges that Semler Scientific did not disclose an investigation by the DOJ into possible violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [2]. - On February 28, 2025, Semler Scientific revealed it had received an initial civil investigative demand from the DOJ in July 2017, concerning the marketing of tests using photoplethysmography technology as reimbursable by Medicare [3]. - Following unsuccessful settlement discussions with the DOJ on February 11, 2025, there was a risk of a civil lawsuit being filed, which led to a stock price drop of $4.03, or 9.38%, closing at $38.89 on March 3, 2025 [3]. Group 2: Settlement and Financial Impact - On April 15, 2025, Semler Scientific reported to the SEC that it had reached a settlement agreement with the DOJ for $29.75 million, excluding attorney fees, but noted that further payments might be necessary and the risk of a DOJ lawsuit still exists [4]. - Following the announcement of the settlement, Semler Scientific's stock fell by $3.40 per share, or 9.88%, closing at $31.00 on April 16, 2025 [4]. Group 3: Class Action Participation - Shareholders interested in participating in the class action must submit their paperwork by October 28, 2025, to serve as lead plaintiff, representing other class members [5]. - Shareholders do not need to participate in the case to be eligible for recovery and can remain absent class members if they choose [5].

Market Performance - U.S. stocks traded higher, with the Dow Jones index gaining approximately 0.1% on Monday, closing at 45,856.77. The NASDAQ rose 0.75% to 22,307.16, and the S&P 500 increased by 0.37% to 6,608.41 [1] - Consumer discretionary shares experienced a significant increase of 1.9%, while health care stocks fell by 0.5% on the same day [1] Economic Indicators - The New York Empire State Manufacturing Index declined to -8.7 in September, down from 11.9 in August and below market estimates of 5 [2][10] Commodity Prices - Oil prices increased by 1% to $63.31, while gold rose by 0.3% to $3,698.80. Silver decreased by 0.1% to $42.810, and copper saw a rise of 1% to $4.6975 [5] European Market Performance - European shares were mostly higher, with the eurozone's STOXX 600 rising by 0.47%. Spain's IBEX 35 Index increased by 0.63%, while London's FTSE 100 fell slightly by 0.01%. Germany's DAX 40 gained 0.27%, and France's CAC 40 rose by 1.05% [6] Asian Market Performance - Asian markets closed mostly mixed, with Hong Kong's Hang Seng rising by 0.22%, China's Shanghai Composite falling by 0.26%, and India's BSE Sensex declining by 0.15% [7] Company News - Check-Cap Ltd. (CHEK) shares surged by 261% to $2.68 following a definitive merger agreement with MBody AI. Helius Medical Technologies, Inc. (HSDT) shares increased by 161% to $19.70 after announcing a $1.25 billion SOL-backed treasury strategy with an oversubscribed PIPE offering at $6.88 per share [9] - Robo.ai Inc. (AIIO) shares rose by 43% to $2.0850 after signing a joint venture agreement to establish Robo.ai Industrial City in Dubai [9] - aTyr Pharma, Inc. (ATYR) shares plummeted by 81% to $1.1694 after failing to meet primary endpoints in a Phase 3 study [9] - Avidity Biosciences, Inc. (RNA) shares fell by 7% to $41.68 following a filing for an offering of 15 million shares of common stock [9] - The Hain Celestial Group, Inc. (HAIN) shares dropped by 26% to $1.5894 after reporting worse-than-expected fourth-quarter financial results [9]

Group 1: Rewey Asset Management Overview - Rewey Asset Management's "RAM Smid Composite" increased by 6.11% in Q2 2025, slightly underperforming the benchmark Russell 2500 Value Total Return Index, which gained 7.29% [1] - Year-to-date, the composite returned -1.29%, compared to a 1.03% gain for the benchmark [1] - The firm expresses confidence in the Smid value sector as it approaches the second half of 2025 [1] Group 2: Orthofix Medical Inc. Analysis - Orthofix Medical Inc. (NASDAQ:OFIX) is highlighted as a key stock, with a one-month return of 2.76% and a 52-week loss of 9.80% [2] - As of September 12, 2025, Orthofix's stock closed at $14.91 per share, with a market capitalization of $588.86 million [2] - Rewey Asset Management increased its position in Orthofix Medical Inc. in Q2 2025, following a 45.6% decline from its February high and a 36.1% drop from its 2024 close, viewing it as a compelling valuation opportunity [3] Group 3: Hedge Fund Interest and Comparisons - Orthofix Medical Inc. was held by 25 hedge fund portfolios at the end of Q2 2025, down from 28 in the previous quarter [4] - While Orthofix is acknowledged for its investment potential, the firm believes certain AI stocks present greater upside potential and less downside risk [4]

Group 1 - Boston Scientific Corporation (BSX) is recognized as one of the best defensive stocks to buy, with an upgrade from Oppenheimer to 'Outperform' and a price target of $125 [1][2] - The company has shown a strong performance with a revenue growth of 21.44% over the past 12 months, supported by a robust merger and acquisition strategy [2] - Boston Scientific is projected to have a compound annual growth rate (CAGR) of 11%-13%, indicating a positive outlook for a highly diversified company in the healthcare sector [3] Group 2 - The company achieved a 17% organic revenue growth in the second quarter of 2025, with earnings per share increasing by 23% [3] - Boston Scientific develops and manufactures innovative medical devices and solutions for various complex medical conditions, including cardiovascular, respiratory, digestive, neurological, and urological diseases [4]

Core Insights - GE HealthCare Technologies Inc. (GEHC) has a market capitalization of $34.9 billion and operates in various healthcare segments, including Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics [1] - The company focuses on integrating AI, digital platforms, and data analytics to enhance efficiency and clinical outcomes, emphasizing precision care for personalized diagnosis and treatment [2] Stock Performance - GE HealthCare's stock is currently trading 19.4% below its 52-week high of $94.80, recorded on February 13, and has increased by 4.6% over the past three months, outperforming the Dow Jones Industrial Average's 6.7% rise during the same period [3] - Year-to-date, GEHC's stock has decreased by 2.2%, while the Dow Jones has risen by 7.7%. Over the past 52 weeks, GEHC shares have dropped 12.6%, underperforming the Dow Jones's 11.5% returns [4] Recent Developments - On September 10, GE HealthCare announced its plan to acquire icometrix, a company specializing in AI-powered brain imaging analysis for neurological disorders, which will enhance GEHC's MRI systems and support personalized treatment planning [5] - This acquisition aligns with GE HealthCare's precision care strategy by expanding its neuro solutions portfolio and improving clinical decision support in neurological care, resulting in a 2.6% increase in its shares in the following trading session [6]

Core Insights - Innovative medical technologies are emerging to enhance health management, including a pen for Parkinson's disease screening and an AI fundus camera for assessing risks of hypertension and stroke [1][4]. Group 1: Parkinson's Disease Screening - A pen equipped with multiple sensors can assist in the early screening and medication guidance for Parkinson's disease, set to launch next year [3]. - The device detects subtle hand tremors and muscle pressure while holding the pen, providing data for early diagnosis that can be shared with healthcare providers remotely [3]. Group 2: AI Fundus Camera - The AI fundus camera has gained significant attention, particularly among elderly audiences, as it can generate risk assessment reports for conditions such as hypertension, diabetes, and strokes from a single eye photo [4]. Group 3: Digestive System Examination - A capsule-sized endoscope is designed for digestive system checks, capturing thousands of images and presenting them in a panoramic view, with capabilities for remote transmission [6]. Group 4: AI in Traditional Chinese Medicine - An AI-driven digital guide named "An An" can recommend medical departments based on multi-round consultations and provide traditional Chinese medicine advice aligned with seasonal changes, utilizing a specialized model already implemented in some hospitals in Beijing [6]. Group 5: Future of Healthcare - The integration of artificial intelligence and big data is reshaping healthcare service models, with expectations for improved service quality as these innovations are further adopted [8].

Group 1 - A pen equipped with sensors can assist in the early screening and medication guidance for Parkinson's disease, set to launch next year [3] - The pen detects subtle hand tremors and muscle pressure during writing, allowing users to send results to their doctors remotely [3] - An AI retinal camera generates risk assessment reports for conditions like hypertension and stroke from a single eye photo, attracting significant interest from older audiences [4] Group 2 - A capsule-sized endoscope for digestive system examinations captures thousands of images and can send panoramic views remotely [6] - An AI-driven digital guide named "An An" offers department recommendations and traditional Chinese medicine advice based on seasonal changes, utilizing a specialized model already implemented in some hospitals in Beijing [6] - The integration of AI and big data is transforming healthcare service models, promising improved service quality with the application of innovative technologies [8]

Accessibility StatementSkip Navigation SAN DIEGO, Sept. 13, 2025 /PRNewswire/ --Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596, and pending in the Central District of California – seeks to represent purchasers or acquirers of RxSight, Inc. (NASDAQ: RXST) securities and charges RxSight as well as certain of RxSight's top executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses ...

Market Overview - U.S. stocks showed mixed performance, with the Dow Jones index falling over 200 points, down 0.44% to 45,904.50, while NASDAQ rose 0.41% to 22,134.26 and S&P 500 gained 0.01% to 6,587.98 [1] - European shares were mixed, with the eurozone's STOXX 600 rising 0.10% and Spain's IBEX 35 Index falling 0.31% [6] - Asian markets closed mostly higher, with Japan's Nikkei 225 gaining 0.89% and Hong Kong's Hang Seng rising 1.16% [7] Consumer Sentiment - The University of Michigan consumer sentiment declined to 55.4 in September from 58 in August, below market estimates of 58 [2][8] Commodities - Oil prices increased by 1.7% to $63.44, gold rose 0.5% to $3,691.50, silver increased by 1.5% to $42.765, and copper rose 0.2% to $4.6680 [5] Company Performance - Allied Gaming & Entertainment Inc. shares surged 113% to $1.9501 after announcing an initial investment in Bitcoin and Ethereum [9] - GlucoTrack, Inc. shares rose 80% to $8.76 following a purchase agreement with Sixth Borough Capital for up to $20 million [9] - IBEX Limited shares increased by 40% to $42.77 after reporting better-than-expected fourth-quarter results and issuing FY26 sales guidance above estimates [9] - Next Technology Holding Inc. shares dropped 54% to $0.1638 after announcing a 200-for-1 reverse stock split [9] - XTI Aerospace, Inc. shares fell 33% to $1.3698 after pricing a $20 million public offering [9] - Frequency Electronics, Inc. shares decreased by 13% to $29.95 after reporting worse-than-expected first-quarter results [9]